|
Balance Sheet Cash Flow Statement Bösch 69 CH-6331 Hünenberg, Zug, Switzerland Tel. +41-41-785-88-88 |
Type: Public
On the web:
http://www.alconlabs.com
Employees:
15,400
Employee growth: 6.2%
Alcon sees all, and hopes you can too. Operating through three divisions, pharmaceutical, surgical, and consumer eye care, the company strives to keep eyes healthy. Its surgical group is the largest maker of equipment used for cataract removal and laser vision correction. Alcon's pharmaceuticals include glaucoma treatments, anti-infectives, and allergy relievers. Its consumer products include the well-known Opti-Free line of contact lens solutions and related products. Alcon sells its products in 180 countries worldwide. Nestlé owns about 50% the company, which was founded in 1945, while pharmaceutical manufacturer Novartis owns about 25%.
Key numbers for fiscal year ending December, 2008:
Sales: $6,293.7M
One year growth: 12.4%
Net income: $2,046.5M
Income growth: 29.0%
Officers:
Chairman: Cary R. Rayment
President, CEO, and Director: Kevin J. Buehler
SVP and CFO: Richard (Rick) Croarkin
Competitors:
Abbott Medical Optics
Allergan
Bausch & Lomb
